JCTLM Database: higher-order reference materials, methods and services
Details : C19RMP11 - ID-LC-MS/MS-based reference measurement procedure for the quantification of methotrexate in human serum and plasma
Type (acronym) | rmp |
Type | reference measurement procedure |
Unique Nomination Number | C19RMP11 |
Analyte Name | methotrexate |
IUPAC IFCC Number | CAS59-05-2 |
Method capable of Traceability of Analyte to SI or Defined Procedure | yes |
Applicable Matrices | human serum and plasma; fresh or frozen
Lithium heparin plasma, K3-EDTA plasma, K2-EDTA plasma |
Name | ID-LC-MS/MS-based reference measurement procedure for the quantification of methotrexate in human serum and plasma |
Organization that developed Validated Method | Labor Berlin - Charité Vivantes Services GmbH in collaboration with Roche Diagnostics GmbH |
Measurement Techniques Used | Isotope dilution mass spectrometry |
Quantity | Mass concentration |
From (0) | 7.2 |
To (0) | 5700 |
Unit (0) | ng/mL |
From (1) | 7.8 |
To (1) | 3.6 |
Unit (1) | % |
Level of Confidence (%) | 95% |
Comments on Uncertainty Range | The lowest expected measurement uncertainty of 7.8 % is at the mass concentration of 24.00 ng/mL.
The highest expected measurement uncertainty of 3.6 % is at the mass concentration of 4200 ng/mL. |
Peer Reviewed Publication | An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of methotrexate in human serum and plasma, Taibon J. et al, Clinical Chemisty and Laboratory Medicine 2023 61(11) 1917-1929
|
Comments to be published via JCTLM DB | This reference measurement procedure was developed and validated by Labor Berlin - Charité Vivantes Services GmbH in collaboration with Roche Diagnostics GmbH |
Analyte Category Name | Drugs |
Non-CCQM Key Comparison Report | See CCLM publication cited above for comparability assessment study |
Measurement principle/technique | Isotope dilution mass spectrometry |